Literature DB >> 11978148

Electrocardiographic and hemodynamic effects of Panax ginseng.

Michael F Caron1, Audrea L Hotsko, Stacy Robertson, Lilia Mandybur, Jeffrey Kluger, C Michael White.   

Abstract

OBJECTIVE: To determine whether Panax ginseng ingestion can acutely or chronically alter electrocardiographic parameters: PR, QRS, QT, QTc, and RR intervals, and QT and QTc interval dispersion. Effects of P. ginseng on blood pressure and heart rate also were evaluated.
METHODS: This is a prospective, randomized, double-blind, placebo-controlled study of healthy adults at the University of Connecticut. Thirty subjects were randomly allocated to receive 28 days of therapy with either P. ginseng extract 200 mg or placebo. Baseline 12-lead electrocardiograms (ECGs) were obtained. Subsequent ECGs were performed following study drug ingestion at 50 minutes, 2 hours, and 5 hours on days 1 and 28. Blood pressure readings were taken with each ECG.
RESULTS: P. ginseng ingestion increased the QTc interval by 0.015 seconds on day 1 at 2 hours compared with the placebo group (p = 0.03). It also reduced diastolic blood pressure from 75 +/- 5 mm Hg at baseline to 70 +/- 6 mm Hg at the same time point (p = 0.02). The observed effects are not believed to be clinically significant. No other statistically significant changes were found in electrocardiographic or hemodynamic variables on days 1 or 28.
CONCLUSIONS: P. ginseng, at doses of 200 mg of the extract daily, increases the QTc interval and decreases diastolic blood pressure 2 hours after ingestion in healthy adults on the first day of therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11978148     DOI: 10.1345/aph.1A411

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  17 in total

1.  Blood pressure-lowering effect of Korean red ginseng associated with decreased circulating Lp-PLA2 activity and lysophosphatidylcholines and increased dihydrobiopterin level in prehypertensive subjects.

Authors:  Tae Woong Cha; Minjoo Kim; Minkyung Kim; Jey Sook Chae; Jong Ho Lee
Journal:  Hypertens Res       Date:  2016-02-04       Impact factor: 3.872

Review 2.  What do most erectile dysfunction guidelines have in common? No evidence-based discussion or recommendation of heart-healthy lifestyle changes and/or Panax ginseng.

Authors:  Mark A Moyad; Kwangsung Park
Journal:  Asian J Androl       Date:  2012-09-24       Impact factor: 3.285

Review 3.  Therapeutic potential of ginseng in the management of cardiovascular disorders.

Authors:  Morris Karmazyn; Melissa Moey; Xiaohong Tracey Gan
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

Review 4.  Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension.

Authors:  Morris Karmazyn; Xiaohong Tracey Gan
Journal:  Mol Cell Biochem       Date:  2020-09-17       Impact factor: 3.396

Review 5.  Herbs and alternative therapies: relevance to hypertension and cardiovascular diseases.

Authors:  Chaula K Vora; George A Mansoor
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

Review 6.  Ginseng compounds: an update on their molecular mechanisms and medical applications.

Authors:  Jian-Ming Lü; Qizhi Yao; Changyi Chen
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

7.  Nitric oxide-dependent modulation of the delayed rectifier K+ current and the L-type Ca2+ current by ginsenoside Re, an ingredient of Panax ginseng, in guinea-pig cardiomyocytes.

Authors:  Chang-Xi Bai; Kentaro Takahashi; Haruko Masumiya; Tohru Sawanobori; Tetsushi Furukawa
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

Review 8.  The effect of ginseng (genus Panax) on blood pressure: a systematic review and meta-analysis of randomized controlled clinical trials.

Authors:  A M Komishon; E Shishtar; V Ha; J L Sievenpiper; R J de Souza; E Jovanovski; H V T Ho; L S Duvnjak; V Vuksan
Journal:  J Hum Hypertens       Date:  2016-04-14       Impact factor: 3.012

9.  Study designs of randomized controlled trials not based on Chinese medicine theory are improper.

Authors:  Jian Yan; Veronica F Engle; Yuxin He; Yan Jiao; Weikuan Gu
Journal:  Chin Med       Date:  2009-02-25       Impact factor: 5.455

10.  Effects of Korean Red Ginseng on Cardiovascular Risks in Subjects with Metabolic Syndrome: a Double-blind Randomized Controlled Study.

Authors:  Byoung-Jin Park; Yong-Jae Lee; Hye-Ree Lee; Dong-Hyuk Jung; Ha-Young Na; Hong-Bae Kim; Jae-Yong Shim
Journal:  Korean J Fam Med       Date:  2012-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.